Market Place
Sourcing Support
Haryana FDA Conducts Large-Scale Raid On Fatehabad Pharmacies
30 Jan 2026 //
PHARMABIZ
Allopathic Taint Triggers `X-Plus Gold` Ayurvedic Recall
29 Jan 2026 //
PHARMABIZ
Drug Misuse: Govt May Curb `Pregabalin` Sales
29 Jan 2026 //
ECONOMICTIMES
Neogen Recalls Neogen Vet HYCOAT Hyaluronate Sodium Nationwide
28 Jan 2026 //
BUSINESSWIRE
China Halts Sale of Sun Pharma Drug Used to Treat Dementia
27 Jan 2026 //
REUTERS
Sun Pharma, Cipla Recall U.S. Products Over Manufacturing Issues
26 Jan 2026 //
ECONOMICTIMES
NIH bans use of aborted fetal tissue in research
23 Jan 2026 //
FIERCE PHARMA
Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa
22 Jan 2026 //
PHARMABIZ
IPC Developing IP Reference Standards For Anti-Tb Drug
22 Jan 2026 //
PHARMABIZ
Over 160 Drug Samples Found Sub-Standard In December
21 Jan 2026 //
ECONOMICTIMES
LOTTE Biologics Strengthens Global Quality With Syracuse ADC Hub
19 Jan 2026 //
BIOSPACE
FDA Proposes Febrile Seizure Warnings on Flu Shot Labels
17 Jan 2026 //
FIERCE PHARMA
FDA Observation to Hit Lanreotide supply; Cipla may face earnings
16 Jan 2026 //
BUSINESS STD
Former Emergent CEO Hit With Insider Trading Lawsuit
16 Jan 2026 //
BIOSPACE
Experts Urge Scrutiny of Fake ISO Certs for Medical Devices
15 Jan 2026 //
PHARMABIZ
Compounder Sues Lilly, Novo, Claims Coordinated Crackdown
15 Jan 2026 //
BIOSPACE
IPA-CPD Urges Health Ministry To Mandate Red Line On Antibiotic
14 Jan 2026 //
PHARMABIZ
Jharkhand DCA Seeks Correction on CDL Kolkata Cough Syrup Report
14 Jan 2026 //
PHARMABIZ
FDA Issues First Two Untitled Letters In 2026 Enforcement Drive
14 Jan 2026 //
RAPS
Nestle Steps up Infant Formula Damage Limitation
14 Jan 2026 //
REUTERS
Delhi HC Restores Ban On 2 Diabetes FDCs
14 Jan 2026 //
ECONOMICTIMES
DoP May Exempt 11 More Drugs from Global Tenders
13 Jan 2026 //
PHARMABIZ
India Cracks Down on Toxic Contaminants in Kids` Medicines
13 Jan 2026 //
PHARMABIZ
AbbVie, Amgen, Lilly Urge FDA to Update Post-Approval Rules
13 Jan 2026 //
BIOSPACE
FDA Issues Warning Letters For GMP, GCP Violations
13 Jan 2026 //
RAPS
US FDA Requests Removal of Suicide Warnings From Weight-loss Drug
13 Jan 2026 //
REUTERS
Telangana DCA Boosts Enforcement Through Global Synergy in 2025
12 Jan 2026 //
PHARMABIZ
Puducherry DC Dept Mandates 100% Testing to Fight Fakes
09 Jan 2026 //
PHARMABIZ
Quality Trailblazer Stresses Non-Negotiable Leadership Commitment
09 Jan 2026 //
EXPRESSPHARMA
Global Drug Regulation Lessons From Nimesulide On Patient Safety
09 Jan 2026 //
EXPRESSPHARMA
Aurobindo Pharma`s Dyrupeg Faces Health Canada Compliance Notice
09 Jan 2026 //
ECONOMICTIMES
Haryana FDA Detects 33 Overpricing Violations In 2025
08 Jan 2026 //
PHARMABIZ
Telangana DCA Unveils Crackdown On Interstate Fake Medicine
07 Jan 2026 //
PHARMABIZ
Wyoming Supreme Court Throws out Abortion Bans
06 Jan 2026 //
REUTERS
Haryana FDA Issues Directive On High-Risk Solvents Labelling
05 Jan 2026 //
PHARMABIZ
India Proposes Ban On OTC Syrup Sales Post Contamination Crisis
05 Jan 2026 //
RAPS
Haryana & Telangana Crack Down On Nimesulide Over 100 Mg
03 Jan 2026 //
PHARMABIZ
NPPA Awaits Recovery Of 85% Overcharged Amount
31 Dec 2025 //
PHARMABIZ
TN DCA Reveals 364 Safety Violations as Coldrif Survivor Returns
31 Dec 2025 //
PHARMABIZ
UK Regulator Warns of Risky Online Treatments
31 Dec 2025 //
INDPHARMAPOST
Government Bans Nimesulide Oral Formulations Above 100 mg
31 Dec 2025 //
ECONOMICTIMES
Corcept Gets Complete Response Letter For Relacorilant
31 Dec 2025 //
BUSINESSWIRE
Doctors Warn Against Antibiotic Misuse As Resistance Threat Grows
29 Dec 2025 //
ECONOMICTIMES
NPPA Permits Serum Institute To Halt Production Of 2 TT Vaccine
29 Dec 2025 //
PHARMABIZ
IIL Confirms Removal Of Counterfeit Abhayrab Rabies Vaccine
27 Dec 2025 //
ECONOMICTIMES
Drug Firms Extend GMP Compliance Time, States IDMA
27 Dec 2025 //
ECONOMICTIMES
Sun Pharma Arm Recalls 17K+ Antifungal Shampoos in US
25 Dec 2025 //
ECONOMICTIMES
Panel Urges Stringent Penalties For False Ayush Ads
24 Dec 2025 //
PHARMABIZ
CDSCO Reports 205 Samples As NSQ In November
23 Dec 2025 //
PHARMABIZ
TGA Seeks Feedback On Medicine Label Changes In Australia
22 Dec 2025 //
RAPS
Shape Memory Medical Obtains EU MDR Certification For IMPEDE
22 Dec 2025 //
BUSINESSWIRE
FDA Posts Warning Letters To Manufacturers Of Breast Binders
19 Dec 2025 //
RAPS
Minnesota Jury Awards $65.5M vs. Johnson & Johnson
19 Dec 2025 //
BUSINESSWIRE
BMS’ Cobenfy TV Ad Is Latest Target Of FDA Untitled Letter Spree
19 Dec 2025 //
FIERCE PHARMA
AZ To Pull Bleeding Reversal Agent After FDA Flags Risk Imbalance
19 Dec 2025 //
FIERCE PHARMA
FDA hit Catalent`s Maryland Manufacturing Sites with Form 483
19 Dec 2025 //
FIERCE PHARMA
FDA Cancels 13 Stores, Suspends 32 Intoxicant tablets Licenses
18 Dec 2025 //
ECONOMICTIMES
Health Ministry Drafts Amendments To MDR, 2017
18 Dec 2025 //
PHARMABIZ
FDA Issues `OAI` To Sun Pharma`s Baska facility After Inspection
18 Dec 2025 //
ECONOMICTIMES
FDA Issues Form 483 with 5 Observations to Aurobindo Unit
18 Dec 2025 //
ECONOMICTIMES
